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Abstract  
There are high rates of depression in people with obstructive sleep apnea (OSA) in both 
community and clinical populations. A large community study reported a rate of 17% 
and reports for sleep clinic samples range between 21% and 41%. A large cohort study 
found OSA to be a risk factor for depression, but we are unaware of any longitudinal 
study of the reverse association. However correlations have not generally been found in 
smaller studies. Well-designed longitudinal studies are needed to examine temporal 
relationships between the two conditions and further research is needed to establish the 
role of confounders, and effect modifiers such as gender, in any apparent relationship. 
Symptoms common to OSA and depression, such as sleepiness and fatigue, are 
obstacles to determining the presence and severity of one condition in the presence of 
the other, in research and clinically. Sleep clinicians are advised to consider depression 
as a likely cause of sleepiness and fatigue. Several possible causal mechanisms linking 
OSA and depression have been proposed but not established. Patients who have 
depression as well as OSA appear worse off than those with OSA only, and depressive 
symptoms persist in at least some patients in short term studies of treatment for OSA. 
Direct treatment of depression in OSA might improve acceptance of therapy, reduce 
sleepiness and fatigue and improve quality of life, but intervention trials are required to 
answer this question.  
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 Introduction 
Obstructive sleep apnea (OSA) is a common disease, characterised by repetitive upper 
airway obstruction during sleep and associated with increased morbidity and mortality 
and diminished quality of life. Depression, a major cause of disease burden and a 
cardiovascular risk factor, appear to be prevalent in OSA and it has been proposed that 
depression may be caused by OSA pathology or its symptoms. Existing literature on 
the prevalence, cause and treatment of depression in obstructive sleep apnea (OSA) is 
copious but fragmented, making it difficult to assess research to date on the underlying 
relationship between the two conditions and the impact of treatments in patients with 
both conditions. This paper therefore reviews the prevalence of depression in OSA, 
evidence for causal links, possible causal mechanisms, and the impact of OSA and 
depression therapies. It then highlights practice points and research needed, shown by 
the review. 
 
Methodological issues 
Several methodological issues need to be taken into account in reviewing this field. 
These include definitions of depression in the OSA-depression literature, how 
depression is measured, possible confounders to be considered when assessing 
prevalence and correlational studies, and referral and reporting biases. 
Definition and measurement issues 
Multiple measurement instruments 
The use of different techniques to identify both depressive symptoms or disorder and 
sleep breathing disorders are one source of possibly misleading variation between 
studies. For example, in prevalence studies depression has been identified using the 
Sleep Eval expert system, a self-completed measurement scale (BDI), self-report of 
suffering from depression and clinician diagnosis of depression, the last of these 
generally indicating lower prevalence in other settings. More consistency in choice of 
measures would allow for more reliable comparisons and syntheses. 
 
Diagnosis vs symptom counts 
Stringent identification of depression relies on structured medical interviews using 
Diagnostic and Statistical Manual of Mental Disorders, DSM-IV classification rules e.g. 
the Schedules for Clinical Assessment in Neuropsychiatry or Composite International 
Diagnostic Interview. The DSM-IV appears to be relatively unaffected by the presence 
of some co-morbid chronic illnesses,1 and in using DSM-IV interviewers are instructed 
to disregard symptoms directly attributable to the co-morbid illness. However, 
diagnosis, especially in the primary care setting is often less formalised.2 Specialist 
resources required for firm diagnosis of both OSA and depressive illness are also not 
feasible for large scale prevalence studies therefore rating scales of symptoms 
measures must be used and these give higher rates.. 
Symptom specificity 
Common symptoms in OSA and depression are obstacles for determining the 
presence and severity of one condition in the presence of the other, both in research 
studies and clinically. Overlapping complaints include fatigue, loss of interest, 
decreased libido and poor concentration.3 By including complaints like these, several 
frequently used scales of depressive symptoms may not be valid for use in some 
physical disorders4 5 including OSA.6-8 Attempts to overcome the difficulty of measuring 
depressive symptoms where OSA is likely to produce similar symptoms range from 
study-specific modifications to existing scales9 to suggestions that only cognitive 
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features of depression, such as feelings of guilt or worthlessness, self-blame 
ruminative thoughts and crying, should be used in OSA.10   While commonly used 
depression scales have been validated for various patient groups, specifically the HAD-
D11 there do not appear to be validation studies in OSA despite the frequent 
assessment of mood in OSA research. It appears that studies are needed to evaluate 
the validity of various depression scales, and variants, in OSA. Overlapping symptoms 
can also add confusion to clinical diagnosis of both depression and OSA.  
How cardinal are “cardinal” symptoms? 
Though excessive daytime sleepiness (EDS) and fatigue are regarded as signs of 
OSA, empirical evidence does not support a strong association12, 13 and sleep 
physicians also need to be alert to other causes of these symptoms. Fatigue in 
particular is amongst the most common of complaints in primary care, and associated 
with an increased likelihood of psychiatric disorders.14 Bixler and colleagues 15 in a 
USA cohort found depression and then BMI, age, sleep duration, diabetes, and 
smoking to be the most significant risk factors for EDS, as measured by two study-
specific questions about daytime sleepiness. Presence of OSA (defined as OHI ≥ 15) 
did not make a significant contribution to the regression model. Sleepiness was also 
related to depression but not AHI and less strongly to oxygen saturation in a Swiss 
study of snorers, OSA patients and controls.3 Similarly, in two studies of untreated OSA 
patients in the USA, depressive symptoms were stronger predictors of fatigue than 
OSA severity and, individually, neither RDI nor oxygen saturation were significantly 
predicted by fatigue.16 On the other hand, a study of 230 Japanese male patients 
showed AHI and personality characteristics, but not depression scores, as related to 
daytime sleepiness. 17.  
 
 
Relationships suggested by these studies are represented in Fig 1.  
 
 
 
Figure 1 Causes of excessive daytime sleepiness 
 
Sleep clinicians are advised to consider mood factors (such as depression) and 
metabolic factors (such as obesity and diabetes) as perhaps more likely causes of 
sleepiness and fatigue than OSA and to be liberal in making referrals for assessments 
of these factors.15, 18, 19  
Depression Other 
conditions 
OSA 
Excessive daytime sleepiness 
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Possible confounders and effect modifiers affecting prevalence and 
correlational studies 
Any relationship between OSA and depressive symptoms found in prevalence studies 
and correlation studies might be at least partially due to uncontrolled confounding 
factors. Obesity is the most commonly suggested confounder but depression and 
obesity do not have a straightforward or consistent association,20 as has also been 
found in some OSA populations.10  
Any confounding by body mass index (BMI) may operate differently for men and 
women. Aloia and colleagues7 measured sleep variables, BMI and depressive 
symptoms in a group of men and women with moderate to severe OSA (clinician 
diagnosed) and without major psychiatric disorder. For the 61 men in their sample RDI 
was independently related to the BDI somatic dimension. For the 32 women, however, 
there was an independent relationship between the cognitive dimension of the BDI and 
BMI.  
While obesity is one possible confounder there may also be relationships between 
depression and medical co-morbidities of OSA. Bardwell and colleagues21 studied 72 
male and female subjects with sleep apnea. They found that associations between 
mood variables and sleep variables disappeared after controlling for age, BMI, and 
hypertension. These authors pointed out that hypertension is rarely included in 
correlation studies and confounding by this variable may explain disparities in other 
studies. An alternative view is that as OSA has been shown to contribute to 
hypertension22 no adjustment should be made. Ohayon’s 23 large European cross-
sectional study found that the association between sleep breathing disorder and major 
depression persisted even when obesity and hypertension were taken into account. 
Other factors associated with depression, such as age, gender, marital status, 
education, and income24 and other chronic medical illnesses 25 could be included as 
possible confounders in observational studies of depression in OSA. 
Alcohol consumption is associated with depression and warrants consideration as a 
possible confounder or effect modifier in studies of relationships between depression 
and OSA. Though acute administration of alcohol to subjects with at least mild OSA 
has increased apneas and hypopneas in some experiments,22, 26 epidemiological 
studies are inconsistent in finding associations between self-reported alcohol use and 
OSA.22 27  A recent Swedish study showed blood alcohol levels in OSA patients 
consistent with usual population rates of alcohol abuse, supporting earlier findings in 
the UK and Hawaii.28 Overall, therefore, the case is not strong for a direct relationship 
between alcohol use and development of OSA, though for people who have the 
condition, alcohol may worsen OSA symptoms. 
Physical exercise is a further candidate confounding variable. Exercise is associated 
with both reduced depressive symptoms and reduced prevalence of OSA, at least in 
observational studies.29, 30 
Different gender compositions in study samples may introduce further variation by 
effect modification. Studies in OSA which have reported findings by gender show 
higher rates of depression in women than in men31-33. This reflects a more general 
finding for prevalence of depression, 34 and studies in OSA should now report by 
gender. 
 
It is evident that possible confounding and effect modification should be taken into 
account in assessing observational studies. It is also evident that further research is 
needed to establish the role of confounders in the relationship between OSA and 
depression, and that studies should include sufficient numbers of both women and men 
and report results separately for both. An important issue is that analyses rarely test for 
effect modification, assuming simple linear associations and confounding. As shown 
above interactions with gender at least should be considered. 
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Referral and reporting biases 
A further methodological issue to be noted in studies of clinical populations is referral 
bias. For patients who have both OSA and depression, referral bias might operate to 
increase detection of the other condition, if frequent consultations prompt further 
referrals, or to reduce detection of the other condition, if primary care physicians 
attribute symptoms to the first condition only. Clinical OSA populations are also more 
likely to be impaired which would raise the likelihood of a depression. This bias would 
explain a differential association of OSA and depression from correlational studies 
based in clinical populations. 
Another possible bias is symptom over-reporting in people with depression. For 
instance those with depression have a greater tendency to rate sleep more poorly 
compared to PSG measures than people without depression.35 Studies relying on self 
reported measures of sleep, therefore, may provide biased data on relationships 
between objective sleep measures and depression.  
The prevalence of depression in OSA 
Population and community prevalence 
There are few reports of purpose-designed studies to determine the prevalence of 
depression comorbid with OSA in general or primary care populations. A population 
survey sampling 18,980 adults from 5 European countries used the “Sleep-Eval” expert 
system in telephone interviews to identify sleep and depressive disorders. 23 This 
system has not been extensively validated as a screen for depression but is based on 
Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, criteria23. Among the 
857 people identified as having OSA or other type of breathing related sleep disorder, 
the prevalence of major depressive disorder was 17%, while the prevalence for the 
whole sample was 4.3%. A prevalence study using diagnoses recorded in a four year 
period of the healthcare database for USA Veterans Health Administration 
beneficiaries, found that of 4.060,504 unique cases, 118,105 had clinician-diagnosed 
OSA and of these, 21.8% also had clinician-diagnosed depressive disorder. 36 The 
prevalence of depression was 9% in non-apneics (P<0.0001). In the HUSK study of 
over 7,000 working middle aged Norwegians, the 440 participants with OSA symptoms 
had significantly greater mean depression rating scores37. The background prevalence 
of depression among people without OSA in these large-scale studies are consistent 
with earlier findings of 3-5% in community settings and 5-10% in primary care 38 in the 
USA, supporting the credibility of reported higher prevalence among people with OSA. 
Rates in clinical populations 
Other prevalence studies have looked at people entering sleep clinics who were then 
diagnosed with OSA. These studies have generally shown high rates of depression or 
depressive symptoms in OSA patients. Vandeputte 39 found 41% (95% CI 37-44%) of 
167 Dutch sleep clinic referrals diagnosed with OSA according to American Sleep 
Disorders Association classification had a Beck Depression Inventory (BDI) score of 10 
or more, commonly used as indicative of probable depression. Self-reported 
depression rates among 406 people diagnosed with OSA (Apnea Hypopnea Index 
(AHI) ≥15 or AHI≥5 with other problems) in a USA sleep clinic was 30% overall, 38% 
for women and 26% for men. 31 Two further studies also provided data by gender for 
clinical samples. Of 130 women with “documented breathing disorders” randomly 
selected from a Canadian OSA clinical database 21% had a self-reported previous 
diagnosis of depression compared with 7% of 130 matched men from the same 
database.33  Of 29 women entering a USA sleep clinic and diagnosed with OSA 
according to American Academy of Sleep Medicine Task Force 1999 
recommendations, 28% were categorised as having moderate to severe depression 
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(BDI>19) compared with 6% of 92 men given the same diagnosis.32  Variation in rates 
would be expected with differently composed clinical populations from different 
communities, and further variability is added with the use different measures for 
depression or different cut off points. However, these studies report high rates of 
depression or depressive symptoms in people with OSA and point to higher rates 
among women in clinical samples. 
Rates of depression have also been extracted from 24 reports of studies in OSA to give 
a range of 7-63%.40  However, most of the original studies were designed as 
experimental or correlation studies rather than prevalence studies. This range therefore 
reflects rates in small clinical samples after the application of differing sets of 
inclusion/exclusion criteria and not the prevalence of depression in people with OSA in 
populations or usual rates of depression in clinical OSA populations. 
 
In summary, prevalence studies have shown high rates of depression among people 
with OSA in both community and clinical populations. There is variation in reported 
rates, some of which will reflect underlying differences between populations and some 
of which may be attributable to the confounders, effect modifiers, biases and 
measurement issues discussed above.  
Correlational studies  
While depression or depressive symptoms are prevalent in OSA populations, they may 
stem from factors other than OSA. A direct link between OSA and depression would be 
further supported by evidence of dose response and temporal relationships, with 
possible confounding factors investigated. 
Relationships in severity of disease – cross sectional studies 
A relationship between severity of OSA and severity of depressive symptoms would be 
expected if the two conditions were directly linked. In a USA sample of 190 women and 
165 men there was no relationship between depression, measured by the Center for 
Epidemiologic Studies Depression Scale (CES-D) or by atypical depression items from 
the Hamilton Depression Rating Scale-Seasonal Affective Disorders Self-Rating 
(SIGH-SAD-SR) scale, and OSA severity, measured by desaturations.41 Similarly, Pillar 
and Lavie’s 42 large study of 2,271 clinic referrals (Respiratory Distress Index range 
<10 to >33) in Israel found no association for males between RDI and depressive 
symptoms scores using the Symptom Checklist-90 (SCL-90). While in women 
depression scores were higher in those with severe sleep apnea, there was not a 
simple severity relationship across categories of sleep breathing disorder. Simple 
snorers, for example, reported more depressive symptoms than those with mild apnea. 
Smaller studies have also found little or no correlation between the severity of mood 
symptoms and the severity of apnea, potentially as a consequence of being 
underpowered. One study looked at a group of 98 USA male veterans with OSA 
diagnosed by International Classification of Sleep Disorders criteria. Although 37.5% 
had BDI scores in the “clinically significant range” of 15 or more, there was no 
difference between this group and those with lower BDI scores for either AHI or SaO2 
nadir, and no non-significant trends.10 A Polish study (n=63) also found no significant 
differences between men with and without OSA for BDI or CES-D (with mean BDI 
scores highest in the control group).43  Another study of Hamilton Hospital Anxiety and 
Depression Scale depression (HAD-D) scores in 44 Swiss OSA patients and 16 
snorers found no significant correlation with AHI (and a trend, p=0.06, towards a 
negative relationship) but did find a significant positive correlation between mean low 
oxygen saturation and HAD-D score.3  In a USA clinical sample of 61 men and 32 
women, with major psychiatric conditions screened out, there was a significant 
relationship of RDI with BDI total score and with BDI somatic but not cognitive 
dimension, a surprising finding given the limited variability of the BDI score in this 
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highly selected group. Analysis by gender, however, showed an independent 
relationship only for men between RDI and the somatic, but not the cognitive, 
dimension of the BDI. For women, BMI but not RDI was related to only the cognitive 
dimension of the BDI.7  Overall, however, studies have generally failed to find a 
symptom correlation. It should be noted that lack of demonstrated correlation does not 
necessarily mean there is no link between the two conditions. For example, severity of 
depression is not necessarily related to number of symptoms as measured in 
depression scales or the two conditions could be a result of the same underlying 
phenomenon, and a further possibility is a relationship in some but not all individuals 
due to genomic variation.44 
 
A study of an older community sample showed different results for men and women. 
The Cardiovascular Health Study cohort, comprising 5,201 USA residents aged 65 and 
older, measured self-reported partner-observed apneas and assessed depressive 
symptoms using the CES-D. Results of this study were reported by gender and an 
association between depression and observed apneas was found in women but not in 
men.45  A weakness of this study is reliance on witnessed apneas, a weak predictor of 
OSA.45   
Relationships in disease onset 
Stronger evidence of a causal link is obtained from prospective longitudinal studies. 
One large-scale cohort study has shown an increased risk of developing depression as 
OSA develops or worsens, and a dose-response relationship between severity of OSA 
and, importantly, odds of developing depression.9  Polysomnography (PSG) and a 
modified Zung Depression Scale were administered to 1,408 community subjects at 
multiple 4-year intervals. Depression was defined as Zung score of at least 50 or 
antidepressant use. Moving from one OSA severity level to a higher one during a 4 
year period was associated with a 1.8 odds ratio of developing depression during the 
same period. There was also a consistent severity relationship. In models controlled for 
age, BMI, alcohol consumption and history of cardiovascular disease, people within 
each OSA severity category were at greater risk of having developed depression than 
those in less severe categories. While purely cross sectional studies have not shown 
clear severity relationships, 4-year interval data in this large adult population sample 
did show an association between OSA severity and risk of developing depression, as 
well as development of depression alongside worsening of OSA.  
Retrospective studies have also shown that patients diagnosed with OSA are at 
increased risk of having had a diagnosis of depression.46, 47  These studies do not show 
the order of onset of actual disease however, and diagnoses of depression may have 
been given incorrectly on the basis of symptoms that are common to both conditions.  
Longitudinal studies are still needed to determine whether one condition follows the 
other in different contexts. 
 
As noted earlier, possible explanations for differing findings among observational 
studies include hidden confounders or effect modifiers in some study samples.  
  
Correlational studies are summarised in Table 1. 
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Table 1. Summary of correlational studies 
 
First 
author / 
date 
Study 
population  
Depression 
measure/s  
OSA 
measure/s 
Study conclusions 
Cross –sectional studies 
Enright / 
199645 
 
5,201 community 
sample 65 years 
and older (2,239 
men) 
CES-D. Self-reported 
partner-
observed 
apneas 
Association between depression 
and observed apneas found in 
women but not in men. 
Kripke / 
199741 
Community sample 
of 355 (165 men) 
CES-D or 
items from 
SIGH-SAD-SR 
Desaturations No relationship 
Pillar / 
199842 
2,271 referrals 
(1,977 men) to 
sleep clinic 
SCL-90  RDI No consistent relationship  
Sforza / 
20023 
44 OSA patients 
and 16 snorers, 
genders not given 
(HAD-D) 
 
AHI, mean 
low oxygen 
saturation 
No correlation between AHI and 
HAD-D score. Positive correlation 
between mean low oxygen 
saturation and HAD-D score 
Smith / 
200246 
Records of 773 
patients with OSAS 
(599 men) and 
matched controls 
from the general 
population 
Physician 
diagnosis  
Physician 
diagnosis 
OSA patients had OR 1.4 (95% CI, 
1.0 to 1.9) of past depression 
 
Aloia / 
20057 
Sleep clinic sample 
93 (61 men)  
BDI  RDI Relationship of RDI with BDI total 
score and with BDI somatic 
dimension. By gender, independent 
relationship between RDI and 
somatic dimension only for men.  
Farney / 
200447 
Records of 212,972 
patients (102,614 
men) 
Prescription 
for 
antidepressant 
medications 
Physician 
diagnosis 
Likelihood of having OSA 
increased in depression. 
Cohort study 
Peppard 
/ 20069 
1,408 community 
subjects (788 men) 
Modified Zung 
Depression 
Scale or 
antidepressant 
use 
PSG 
 
 
1.8 odds ratio of developing 
depression within a 4-year interval 
as OSA develops or worsens. 
Dose-response relationship 
between severity of OSA and odds 
of developing depression  
 
Impact of therapies 
Impact of OSA therapies on depression 
If there is a direct causative link between OSA and the onset of depression, then 
depression would be expected to improve with successful treatment of OSA. While 
improvements in depression scores have been reported in some 6, 48-50 but not all 51 
studies without placebo arms, the weakness of such uncontrolled designs has been 
highlighted by reports of a large placebo effect for depression scores both generally52 
and in OSA.53, 54 A recent Cochrane meta-analysis covered randomised controlled trials 
published before mid 200555. This meta-analysis confirmed that continuous positive 
airway pressure (CPAP) therapy was effective in reducing sleepiness and improving 
quality of life measures in OSA. Results for the HADS depression scale were also 
extracted from five clinical trials comparing CPAP with placebo and while pooled fixed 
effects significantly favoured CPAP, there was no significant effect of CPAP treatment 
after the application of random effects modelling. In addition to these trials employing 
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HAD-D, a further study56 included in the Cochrane review employed the Geriatric 
Depression Scale. No significant difference was found between control and intervention 
arms for change in this scale. Two new randomised controlled trials54, 57 published 
since the Cochrane review found no mood improvement associated with CPAP. 
However, both studies measured outcomes after only 2 weeks of CPAP treatment, and 
intervention studies in depression typically take 4 to 6 weeks to show any significant 
effect, primarily due to large response to the first treatment/control in both groups. 
Additionally, one study54 employed the POMS scale rather than a specific depression 
instrument and the other,57 using BSI depression subscale, may have been under-
powered. Of interest is a comparison in one of these studies57 between CPAP and 
oxygen therapy. While the sham CPAP group showed no improvement in depression 
scores, and the therapeutic CPAP group showed a non-significant trend to 
improvement, the oxygen therapy group showed significant improvement. Investigators 
suggest that for patients unable to adhere to CPAP, nocturnal oxygen supplementation 
may improve psychological functioning.  
An ongoing large scale trial (n=1,100) in moderate to severe OSA, the Apnea Positive 
Pressure Long-term Efficacy Study or APPLES, currently being conducted in the USA, 
may provide more information. A secondary aim of APPLES is to show whether CPAP 
improves depression scores in moderate to severe OSA. APPLES enrolment includes 
patients with clinical depression therefore may show whether or not CPAP therapy is 
effective against depression that is comorbid with OSA. If CPAP is ineffective in 
treating clinical depression in OSA, large-scale trials will be needed to test other 
interventions. 
Oral appliance (OA) therapy is an alternative to CPAP which improves subjective 
sleepiness and sleep disordered breathing.58 Unfortunately, few trials of OA therapy 
have included depression measures. One trial59 showed similar BDI improvement for 
OA, CPAP and placebo from a baseline mean of 9.2. Another60 showed significant 
improvement in the somatic but not cognitive component or total score of the BDI with 
OA, with baseline mean only 5.8.  
Overall, evidence to date suggests that depressive symptoms may persist in at least 
some patients receiving CPAP or other treatment for OSA. 
 
Varied results in controlled trials on the effectiveness of CPAP and OA treatment in 
reducing depressive symptoms may be due to differences between study designs, 
such as duration of intervention and choice of control condition, to differences between 
study populations in gender mix and initial severity of OSA and depression, or to 
measurement problems. Research could be conducted to isolate any variables which 
are associated with reduction of depressive symptoms when OSA is treated. As clinical 
trials to date have included patients with depression scores mainly in the non-clinical 
range where there may be floor effects of any intervention, trials are needed to assess 
the effectiveness of CPAP in alleviating clinically relevant levels of depression. On the 
other hand, a reduction in “depressive” symptoms across the severity range may imply 
that the CPAP is having an effect upon epiphenomena such as tiredness and 
motivation rather than depression per se. 
Therapies for depression 
Higher rates depressive disorder and depressive symptoms are a common finding in 
virtually every chronic medical illnesses, particularly those associated with pain and 
disability with causation now being proposed in both directions and somatic symptoms 
strongly associated with depressive symptoms.25, 61, 62 Active monitoring, and treatment 
of depressive illness which results in undue distress or greater impairment, is proposed 
both for chronic illnesses generally25, 61, 62 and in sleep medicine where comorbid 
depression might reduce patient adherence to CPAP as well as contribute to disease 
burden.18, 19, 63 Trials are now being conducted to assess the effect of enhanced 
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depression care on symptom burden, self-care and costs in chronic medical illnesses. 
Some64, 65 though not all1 trials completed in other conditions have shown benefits. 
Such trials could be considered in OSA, especially as CPAP alone does not appear to 
reliably treat co-morbid depression. In addition, the possibility of worse chronic illness 
outcomes for patients who do not respond to treatment for comorbid depression66 has 
not been examined in OSA.  
 
Altered sleep architecture, including increased rapid eye movement sleep (REM) is 
seen in depression 67 and further sleep changes may be caused by some 
antidepressive medications. Reduced REM sleep percentage, found in many studies of 
normal and depressed subjects who have been given common classes of 
antidepressants, 68 is also found in OSA subjects, though without an apparent effect on 
apnea frequency69 Both tricyclic and selective serotonin reuptake inhibitor 
antidepressants may also lower sleep efficiency in patients with OSA.69 Data on 
differential effects of antidepressant drugs is available, at least for non-OSA subjects, 
to assist with choice of depression therapy in OSA.68   
The impact of depression on OSA 
Comorbid depression has been found to impact adversely on self-management, 
treatment adherence and functioning and to increase symptom perception and health 
care cost in other chronic medical illnesses.38, 62 Though there has been little research 
on the impact of depression in OSA, patients who have depression as well as OSA 
also appear worse off than their counterparts with OSA only. OSA patients with high 
levels of depression are those with most daytime sleepiness,18 fatigue, 16 and lowest 
quality of life scores.70 Reports are inconsistant on CPAP compliance. In a pre-post 
study of 54 new OSA patients, neither pre-CPAP depression scores nor post-CPAP 
improvement in these scores were related to use of CPAP.71 However, in a 
questionnaire study of 178 patients who had earlier been given CPAP, depression was 
associated with low compliance.18  Treatment of depression might improve acceptance 
of CPAP, reduce sleepiness and fatigue and improve quality of life, but this remains to 
be tested.  
Possible basic mechanisms 
If the observation from one longitudinal study is repeated, showing OSA to be a risk 
factor for the onset of depression, basic mechanisms will be of interest. Existing data 
suggests some potential pathophysiological links  
Effects of sleep fragmentation and hypoxia on mood  
Noting that early studies showing links between depressive symptoms and sleep 
fragmentation or hypoxia in OSA had small numbers of patients and did not control for 
likely confounders, Bardwell 21 with n=72 showed no relationship between depression 
and either sleep fragmentation or hypoxia when BMI and hypertension were controlled. 
Bardwell and colleagues57 later compared the effects of CPAP and oxygen therapy on 
depressive symptoms in a controlled randomised trial in 38 people with OSA. While 
other arms showed no significant effect, the oxygen therapy arm showed significant 
reduction in psychological symptoms. Authors concluded that in patients with OSA 
hypoxaemia may play a stronger role than sleep disruption in depression. In contrast, a 
case-control study72 showed psychological symptoms to be correlated with sleep 
fragmentation but not with oxygen desaturation. However, this conclusion was drawn 
using the 10 most commonly checked items on the SCL-90 rather than the depression 
sub-scale. 
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Possible common neurotransmitter disturbances  
Obstructive sleep apnoea is associated with elevated levels of the cytokines IL6 and 
tumour necrosis factor.73, 74 These cytokines have been proposed as the mediators of 
daytime sleepiness in this condition. Administration of a tumour necrosis factor 
antagonist has been shown to dramatically reduce the level of daytime sleepiness in 
patients with obstructive sleep apnoea. 75  Major depression has also been shown to be 
associated with an immune response involving proinflammatory cytokines IL 1, IL 6 and 
interferon. 76 While these studies involve small numbers of subjects and do not imply 
causation, they do suggest a possible shared pathway between these conditions. 
Further, obesity, particularly visceral obesity is also associated with an elevation in 
these cytokines and thus might be a confounder. 73 
Abnormalities in central and peripheral neurotransmission of serotonin have been 
implicated as a potential cause of major depression.77 Serotonin is also thought to be 
involved in the sleep dependant reduction in output to the upper airway dilator muscles, 
particularly the hypoglossal nucleus, although this pathway is extremely complex, with 
multiple receptor subtypes 78. The exact role of serotonin in the hypoglossal nucleus 
has also not been characterized. Again this may suggest a shared pathway.  
A further possibility is an as yet uncharacterised underlying causal mechanism for both 
OSA and depression. 
 
Overall, similar factors may be causative for both OSA and depression, with links 
between the two still uncertain (Figure 2) 
 
 
 
Figure 2.  Possible shared pathways for depression and OSA 
 
Chronic illness burden 
In addition to specific pathophysiological effects of OSA on the brain, another 
possibility is that depression in OSA is secondary to the development of a chronic 
medical illness and its complications and symptoms.38 High prevalence of depressive 
disorder and depressive symptoms is a consistent finding in chronic medical 
illnesses,25, 61 and untreated OSA has been found to reduce quality of life on a par with 
other chronic diseases of moderate severity.22 79 
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Discussion 
Despite a plethora of studies we still have no clear view of the role of OSA in the 
causation of depression. Neither do we know whether successful treatment of OSA 
also improves depressive illness. Depression has not been a primary outcome in trials 
to date but these trials are now needed, and would focus on subjects with clinical levels 
of depression with outcomes including validated measures of depression and 
measures of excessive daytime sleepiness. Markers of individual differences likely to 
influence responsiveness to depression treatments could also be considered in the 
design of new studies.44 80 
Practice points 
- Clinicians should be aware of high rates of depression among people with OSA in 
both community and clinical populations, with rates potentially higher in women 
than in men. 
- Depressive symptoms may better explain EDS and fatigue than measures of OSA 
severity. 
- Depressive symptoms may persist in at least some patients receiving CPAP or 
other treatment for OSA. 
Research agenda 
- Greater consistency in techniques to identify depressive disorder and sleep 
breathing disorders will allow for comparisons between studies and better research 
syntheses. 
- Symptoms common to both depression and OSA mean that commonly used 
depression scales may not be valid in OSA. Formal assessment of depression 
scales could identify a scale or variant of acceptable validity.  
- With different rates of depression and perhaps different causal mechanisms for 
men and women, results of observational and experimental studies should be 
reported by gender. 
- Further research is needed to establish the role of a larger range of possible 
confounders in explaining the prevalence of depression in OSA. 
- Short and, if needed, longer-term longitudinal cohort studies are needed to show 
whether or not OSA increases the risk of later developing depression and vice 
versa 
- Suitably powered trials are needed to assess the effectiveness of CPAP, and 
possibly other treatment options, in OSA populations with greater levels of 
depression than in most trials to date 
- Research is needed to determine whether, and to what extent, comorbidity has a 
greater impact on individuals, family, adherence, mortality  
- Pathophysiological studies should clarify whether the high rates of comorbidity 
reflect causation or two conditions which are manifestations of common underlying 
alterations 
- Studies are needed to support decisions on how we should treat depression in 
OSA for example with antidepressants vs. CBT ( and the effect of such treatment 
on a range of outcomes including fatigue, sleepiness, and compliance 
- The sequelae of being a non responder to treatment for depression should be 
followed  
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